Web Exclusive
Markets have over-reacted to Omicron Covid variant; buy the dips: Analysts

Global equity markets, including India, have seen a sharp sell-off over the past few sessions as the Omicron Covid variant reignited concerns of sporadic lockdowns and limit movement of goods and people across key economies. Analysts, however, believe that the markets have overreacted to the development and a market fall from here on, if any, should be used to add to positions from a medium-to-long term perspective. "It will likely take weeks before enough information on the Omicron variant is available to know whether it is the major threat that markets seem to fear. Even if existi.....
Global equity markets, including India, have seen a sharp sell-off over the past few sessions as the Omicron Covid variant reignited concerns of sporadic lockdowns and limit movement of goods and people across key economies. Analysts, however, believe that the markets have overreacted to the development and a market fall from here on, if any, should be used to add to positions from a medium-to-long term perspective.

"It will likely take weeks before enough information on the Omicron variant is available to know whether it is the major threat that markets seem to fear. Even if existing vaccines don't protect against it and it is more transmissible and virulent than other vaccines, we would not panic, as pharmaceutical companies have expressed confidence that they can re-engineer their vaccines to protect against it – so this does not mean we are going back to the dark days of 2020," wrote analysts from the global market strategist team at Invesco in a November 29 note.

The omicron variant was labelled a ‘variant of concern’ by the World Health Organization (WHO) last Friday that sent global equity markets into a tailspin. As a result, the BSE Sensex and Nifty tanked nearly 3 per cent each in a broad-based sell-off. On Monday, however, the markets staged a pullback with both the indexes trading 0.5 per cent higher at 57,404 and 17,099 levels, respectively in intra-day trade.

G Chokkalingam, founder and chief investment officer at Equinomics Research also echoes a similar view and said that the markets have reacted too sharply and too soon. The recent fall, he said, has corrected the rich valuation and made Indian markets more attractive for investors to buy from a medium-to-long term perspective.

"The global markets have overreacted without waiting for the scientific assessment of Omicron on rate of hospitalisation, death rates and efficacy of existing vaccines. There is a possibility of global equity markets stabilising in this week itself. Thanks to recent corrections, valuation of the domestic equity market has moderated. While trailing Sensex price-to-earnings (PE) has come down to 26.7 from its recent peak level of around 30, and the Nifty trades at reasonable valuation on forward earnings - at 23x FY22E and 20x FY23E earnings," he said.

As a portfolio strategy, those at Invesco suggest investors maintain current allocations, and view any continued sell-off as a buying opportunity. Though markets are unlikely to fall as much as in early 2020, the recent strong gains in cyclical assets suggest scope for a potential correction, they said.

"There is not much information available right now on the new strain for the markets to process; hence, we saw a pullback in the Indian markets on Monday. As things stand, the new Omicron variant is a double-edged sword. If it proves to be less impactful than the Delta variant, markets will stage a sharp recovery. In that case, it may be advisable to buy the dips," said U R Bhat, co-founder and director, Alphaniti Fintech.

Among sectors, the biggest negative impact of the Omicron variant over the next few sessions, experts say, will likely be in assets such as industrial commodities, equities and real estate. Information technology (IT), healthcare and utilities, however, are likely to remain relatively insulated.

Given that Europe was already in the midst of a new Covid wave and lockdowns, and the fact a lot of the discoveries of the new variant are in Europe, European equities could be among the worst performers.

Key stories on business-standard.com are available to premium subscribers only.

Already a premium subscriber?

Subscribe to get an across device (Website, Mobile Web, Iphone, Ipad, and Android Phone applications) access to Premium content, Breaking News alerts, Industry Newsletters, Stock and Corporate news alerts, access to Archives and a lot more.


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel
Read More on

MARKETS

CORONAVIRUS

TRADING STRATEGIES

STOCK MARKET TRADING

STOCK MARKET TURMOIL

GLOBAL MARKETS SELL-OFF

MARKETS

NEWS


Most Read

Markets

Companies

Opinion

Latest News

Todays Paper

News you can use